View in EDS HTML Full Text PDF Full Text

Mapping MAGE-A4 expression in solid cancers for targeted therapies.

Saved in:
Bibliographic Details
Title: Mapping MAGE-A4 expression in solid cancers for targeted therapies.
Authors: Habigt C; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Munich, Penzberg, Germany., Rottey S; Department of Medical Oncology, UZ Gent, Ghent, Belgium., Spanggaard I; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Lopez JS; Phase I Drug Development Unit, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Garralda E; Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain., Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain., Bechter O; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Desai J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Galot R; Université Catholique de Louvain and Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Gandhi L; Early Drug Development Center, Dana-Farber Cancer Institute, Boston, MA, United States., Heil F; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Munich, Penzberg, Germany., Rieder N; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Munich, Penzberg, Germany., Dimitrov I; CDx Pharma Services Assay Development, Roche Tissue Diagnostics, Tucson, AZ, United States., Quetglas IM; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Zurich, Zurich, Switzerland., Heichinger C; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Basel, Basel, Switzerland., Keshelava N; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Zurich, Zurich, Switzerland., Roller A; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Basel, Basel, Switzerland.
Source: Frontiers in oncology [Front Oncol] 2025 Mar 13; Vol. 15, pp. 1484182. Date of Electronic Publication: 2025 Mar 13 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40151801
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mapping MAGE-A4 expression in solid cancers for targeted therapies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Habigt+C%22">Habigt C</searchLink>; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Munich, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Rottey+S%22">Rottey S</searchLink>; Department of Medical Oncology, UZ Gent, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Spanggaard+I%22">Spanggaard I</searchLink>; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Lopez+JS%22">Lopez JS</searchLink>; Phase I Drug Development Unit, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Garralda+E%22">Garralda E</searchLink>; Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Calvo+E%22">Calvo E</searchLink>; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bechter+O%22">Bechter O</searchLink>; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Desai+J%22">Desai J</searchLink>; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Galot+R%22">Galot R</searchLink>; Université Catholique de Louvain and Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Gandhi+L%22">Gandhi L</searchLink>; Early Drug Development Center, Dana-Farber Cancer Institute, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Heil+F%22">Heil F</searchLink>; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Munich, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Rieder+N%22">Rieder N</searchLink>; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Munich, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Dimitrov+I%22">Dimitrov I</searchLink>; CDx Pharma Services Assay Development, Roche Tissue Diagnostics, Tucson, AZ, United States.<br /><searchLink fieldCode="AU" term="%22Quetglas+IM%22">Quetglas IM</searchLink>; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Heichinger+C%22">Heichinger C</searchLink>; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Keshelava+N%22">Keshelava N</searchLink>; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Roller+A%22">Roller A</searchLink>; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Basel, Basel, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Mar 13; Vol. 15, pp. 1484182. <i>Date of Electronic Publication: </i>2025 Mar 13 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40151801
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1484182
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1484182
    Titles:
      – TitleFull: Mapping MAGE-A4 expression in solid cancers for targeted therapies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Habigt C
      – PersonEntity:
          Name:
            NameFull: Rottey S
      – PersonEntity:
          Name:
            NameFull: Spanggaard I
      – PersonEntity:
          Name:
            NameFull: Lopez JS
      – PersonEntity:
          Name:
            NameFull: Garralda E
      – PersonEntity:
          Name:
            NameFull: Calvo E
      – PersonEntity:
          Name:
            NameFull: Bechter O
      – PersonEntity:
          Name:
            NameFull: Desai J
      – PersonEntity:
          Name:
            NameFull: Galot R
      – PersonEntity:
          Name:
            NameFull: Gandhi L
      – PersonEntity:
          Name:
            NameFull: Heil F
      – PersonEntity:
          Name:
            NameFull: Rieder N
      – PersonEntity:
          Name:
            NameFull: Dimitrov I
      – PersonEntity:
          Name:
            NameFull: Quetglas IM
      – PersonEntity:
          Name:
            NameFull: Heichinger C
      – PersonEntity:
          Name:
            NameFull: Keshelava N
      – PersonEntity:
          Name:
            NameFull: Roller A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 03
              Text: 2025 Mar 13
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1